General Practice Doctors in Laredo, TX Accepting Medicare

8 General Practice doctors found. Showing 1 - 8

Dr. Ana Maria Pagan, M.D. General Practice Medicare: Accepting Medicare Assignments Practice Location: 1710 E Saunders St, Ste. B490, Laredo, TX 78041 Phone: 956-724-4799    Fax: 956-725-7199

Dr. Oscar Gutierrez-vizuet, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 702 E Calton Rd, Suite 201b, Laredo, TX 78041 Phone: 956-725-6550

Siegfried Pueblitz, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 1700 E Saunders St, Laredo, TX 78041 Phone: 210-617-4445

Jesus I Aguirre-burgos, MD General Practice Medicare: Accepting Medicare Assignments Practice Location: 7210 Mcpherson Rd Ste 220, Laredo, TX 78041 Phone: 956-796-4990

Luis Adrian Ferrer, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 1700 E Saunders St, Laredo, TX 78041 Phone: 787-429-4295

Rafael A Mangual, MD General Practice Medicare: Medicare Enrolled Practice Location: 1515 Pappas St, Laredo, TX 78041 Phone: 956-795-8100    Fax: 956-718-6294

Geisla Zayas Santiago, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 3507 Jaime Zapata Memorial Hwy Ste 5, Laredo, TX 78043 Phone: 956-726-9252    Fax: 956-753-3442

Dr. Kenneth Neil Jones, M.D. General Practice Medicare: Not Enrolled in Medicare Practice Location: 5802 Bob Bullock Loop # C, Ste 328c93, Laredo, TX 78041 Phone: 713-799-9484

News Archive

Violent and unintentional injuries have increased over last few years in the U.S.

The U.S. has experienced a disturbing increase in violent and unintentional injuries over the last few years, reversing positive gains made in the 1980s and 1990s, according to a new study from researchers at the University of Colorado Anschutz Medical Campus and Denver Health Medical Center.

SMI Manufacturing to invest $10 million in HealthSport

HealthSport, Inc., the preeminent formulator and developer of edible, multi-layer film strips that deliver drug and dietary supplement actives through buccal and sublingual absorption as well as oral ingestion, announced today that its strategic manufacturing partner, SMI Manufacturing, has agreed to invest $10 million into HealthSport.

Applications of Artificial Intelligence in COVID-19 ICU and ER situations

The overwhelming increase in critically ill COVID-19 patients, who urgently require intensive care units (ICU) and emergency departments (ED), has challenged healthcare systems worldwide.

Positive results from Genta's Phase 3 trial of Genasense

Genta Incorporated today announced top-line results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine administered with or without Genasense® in patients who have not previously received chemotherapy.

Read more Medical News

› Verified 4 days ago